We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.9M
2
CLF icon
Cleveland-Cliffs
CLF
+$13.6M
3
TPR icon
Tapestry
TPR
+$13.4M
4
ADP icon
Automatic Data Processing
ADP
+$12.2M
5
F icon
Ford
F
+$11M

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTHR
1251
DELISTED
Charles & Colvard Ltd
CTHR
$115K ﹤0.01%
11,889
– –
LFMD icon
1252
LifeMD
LFMD
$172M
$114K ﹤0.01%
57,800
-45,406
-44% -$108K
NRXP icon
1253
NRX Pharmaceuticals
NRXP
$153M
$114K ﹤0.01%
15,370
– –
HNNA icon
1254
Hennessy Advisors
HNNA
$78.5M
$113K ﹤0.01%
13,000
– –
LGF.A
1255
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$111K ﹤0.01%
15,000
– –
STRR
1256
DELISTED
Star Equity Holdings
STRR
$110K ﹤0.01%
22,078
– –
FNCH
1257
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$107K ﹤0.01%
2,142
+376
+21% +$26.1K
CARM
1258
DELISTED
Carisma Therapeutics
CARM
$106K ﹤0.01%
12,500
– –
JRSH icon
1259
Jerash Holdings
JRSH
$63.5M
$106K ﹤0.01%
24,900
– –
SMMT icon
1260
Summit Therapeutics
SMMT
$11.1B
$106K ﹤0.01%
89,100
– –
INSG icon
1261
Inseego
INSG
$90.5M
$104K ﹤0.01%
+5,000
New +$121K
APLT
1262
DELISTED
Applied Therapeutics
APLT
$101K ﹤0.01%
108,800
+50,000
+85% +$60K
SRXH
1263
SRX Global
SRXH
$31M
$101K ﹤0.01%
65
-33
-34% -$117K
XPL icon
1264
Solitario Resources
XPL
$72.9M
$101K ﹤0.01%
205,000
– –
BIOC
1265
DELISTED
Biocept, Inc.
BIOC
$101K ﹤0.01%
3,648
– –
EVK
1266
DELISTED
Ever-Glory International Group, Inc.
EVK
$101K ﹤0.01%
116,500
– –
TXMD icon
1267
TherapeuticsMD
TXMD
$24M
$100K ﹤0.01%
+15,000
New +$121K
TECX
1268
Tectonic Therapeutic
TECX
$606M
$100K ﹤0.01%
13,000
+1,750
+16% +$19.4K
BFI
1269
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$100K ﹤0.01%
38,588
– –
CYCN icon
1270
Cyclerion Therapeutics
CYCN
$16.7M
$99K ﹤0.01%
5,750
– –
SRAX
1271
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$98K ﹤0.01%
57,100
– –
AGIG
1272
Abundia Global Impact Group
AGIG
$36.5M
$97K ﹤0.01%
2,800
-4,000
-59% -$162K
ORKA
1273
Oruka Therapeutics
ORKA
$5.96B
$97K ﹤0.01%
3,912
– –
AMTI
1274
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$97K ﹤0.01%
+100,000
New +$177K
LABP
1275
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$97K ﹤0.01%
14,900
– –
49 50
51
52 53

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.